212 related articles for article (PubMed ID: 22888249)
1. The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs).
Amal H; Ding L; Liu BB; Tisch U; Xu ZQ; Shi DY; Zhao Y; Chen J; Sun RX; Liu H; Ye SL; Tang ZY; Haick H
Int J Nanomedicine; 2012; 7():4135-46. PubMed ID: 22888249
[TBL] [Abstract][Full Text] [Related]
2. The screening of volatile markers for hepatocellular carcinoma.
Qin T; Liu H; Song Q; Song G; Wang HZ; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2247-53. PubMed ID: 20826831
[TBL] [Abstract][Full Text] [Related]
3. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M
Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687
[TBL] [Abstract][Full Text] [Related]
4. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
5. Exploratory Study Using Urinary Volatile Organic Compounds for the Detection of Hepatocellular Carcinoma.
Bannaga AS; Tyagi H; Daulton E; Covington JA; Arasaradnam RP
Molecules; 2021 Apr; 26(9):. PubMed ID: 33922256
[TBL] [Abstract][Full Text] [Related]
6. Novel breath biomarkers identification for early detection of hepatocellular carcinoma and cirrhosis using ML tools and GCMS.
Ain Nazir NU; Shaukat MH; Luo R; Abbas SR
PLoS One; 2023; 18(11):e0287465. PubMed ID: 37967076
[TBL] [Abstract][Full Text] [Related]
7. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
[TBL] [Abstract][Full Text] [Related]
8. Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery.
Li X; Wen X; Luo Z; Tian Y; Qian C; Zhang J; Ling R; Duan Y
Clin Chim Acta; 2023 Feb; 540():117236. PubMed ID: 36716910
[TBL] [Abstract][Full Text] [Related]
9. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
Zhou Z; Jiang H; Tu K; Yu W; Zhang J; Hu Z; Zhang H; Hao D; Huang P; Wang J; Wang A; Xiao Z; He C
J Exp Clin Cancer Res; 2019 Jan; 38(1):18. PubMed ID: 30646949
[TBL] [Abstract][Full Text] [Related]
10. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
11. Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
Rodrigues D; Pinto J; Araújo AM; Monteiro-Reis S; Jerónimo C; Henrique R; de Lourdes Bastos M; de Pinho PG; Carvalho M
Metabolomics; 2018 Apr; 14(5):62. PubMed ID: 30830384
[TBL] [Abstract][Full Text] [Related]
12. Investigation of sweat VOC profiles in assessment of cancer biomarkers using HS-GC-MS.
Monedeiro F; Dos Reis RB; Peria FM; Sares CTG; De Martinis BS
J Breath Res; 2020 Feb; 14(2):026009. PubMed ID: 31766027
[TBL] [Abstract][Full Text] [Related]
13. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32649753
[TBL] [Abstract][Full Text] [Related]
14. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32648918
[TBL] [Abstract][Full Text] [Related]
15. Volatile biomarkers from human melanoma cells.
Kwak J; Gallagher M; Ozdener MH; Wysocki CJ; Goldsmith BR; Isamah A; Faranda A; Fakharzadeh SS; Herlyn M; Johnson AT; Preti G
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():90-6. PubMed ID: 23770738
[TBL] [Abstract][Full Text] [Related]
16. Volatile organic compounds for diagnosis of early hepatocellular carcinoma in at-risk patients.
Sukaram T; Tansawat R; Phathong C; Rerknimitr R; Chaiteerakij R
Clin Chim Acta; 2024 Mar; 556():117831. PubMed ID: 38378104
[TBL] [Abstract][Full Text] [Related]
17. A decade's studies on metastasis of hepatocellular carcinoma.
Tang ZY; Ye SL; Liu YK; Qin LX; Sun HC; Ye QH; Wang L; Zhou J; Qiu SJ; Li Y; Ji XN; Liu H; Xia JL; Wu ZQ; Fan J; Ma ZC; Zhou XD; Lin ZY; Liu KD
J Cancer Res Clin Oncol; 2004 Apr; 130(4):187-96. PubMed ID: 14685850
[TBL] [Abstract][Full Text] [Related]
18. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
[TBL] [Abstract][Full Text] [Related]
19. Determination of volatile organic compounds in SW620 colorectal cancer cells and tumor-bearing mice.
Wang G; Li Y; Liu M; Guo N; Han C; Liu D; Li D; Yang M; Peng Y; Liu Y; Yu K; Wang C
J Pharm Biomed Anal; 2019 Apr; 167():30-37. PubMed ID: 30738241
[TBL] [Abstract][Full Text] [Related]
20. A study on volatile organic compounds emitted by in-vitro lung cancer cultured cells using gas sensor array and SPME-GCMS.
Thriumani R; Zakaria A; Hashim YZH; Jeffree AI; Helmy KM; Kamarudin LM; Omar MI; Shakaff AYM; Adom AH; Persaud KC
BMC Cancer; 2018 Apr; 18(1):362. PubMed ID: 29609557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
